Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Richard Chaisson

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Living Beings

Geographic Areas

Baltimore

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hoffmann Christopher J; Charalambous Salome; Fielding Katherine L; Innes Craig; Chaisson Richard E; Grant Alison D; Churchyard Gavin J
HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South Africa.
Dorman Susan E; Johnson John L; Goldberg Stefan; Muzanye Grace; Padayatchi Nesri; Bozeman Lorna; Heilig Charles M; Bernardo John; Choudhri Shurjeel; Grosset Jacques H; Guy Elizabeth; Guyadeen Priya; Leus Maria Corazon; Maltas Gina; Menzies Dick; Nuermberger Eric L; Villarino Margarita; Vernon Andrew; Chaisson Richard E;
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
Martinson Neil A; Moultrie H; van Niekerk R; Barry G; Coovadia A; Cotton M; Violari A; Gray G E; Chaisson R E; McIntyre J A; Meyers T
HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Richard Chaisson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hoffmann Christopher J; Charalambous Salome; Fielding Katherine L; Innes Craig; Chaisson Richard E; Grant Alison D; Churchyard Gavin J
HIV suppression with stavudine 30 mg versus 40 mg in adults over 60 kg on antiretroviral therapy in South Africa.
AIDS (London, England) 2009;23(13):1784-6.
2009: Dorman Susan E; Johnson John L; Goldberg Stefan; Muzanye Grace; Padayatchi Nesri; Bozeman Lorna; Heilig Charles M; Bernardo John; Choudhri Shurjeel; Grosset Jacques H; Guy Elizabeth; Guyadeen Priya; Leus Maria Corazon; Maltas Gina; Menzies Dick; Nuermberger Eric L; Villarino Margarita; Vernon Andrew; Chaisson Richard E;
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
American journal of respiratory and critical care medicine 2009;180(3):273-80.
2009: Martinson Neil A; Moultrie H; van Niekerk R; Barry G; Coovadia A; Cotton M; Violari A; Gray G E; Chaisson R E; McIntyre J A; Meyers T
HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2009;13(7):862-7.
2009: Chaisson R E; Harrington M
How research can help control tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2009;13(5):558-68.
2009: Nachega Jean B; Hislop Michael; Nguyen Hoang; Dowdy David W; Chaisson Richard E; Regensberg Leon; Cotton Mark; Maartens Gary
Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.
Journal of acquired immune deficiency syndromes (1999) 2009;51(1):65-71.
2009: Dowdy David W; Chaisson Richard E
The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection.
Bulletin of the World Health Organization 2009;87(4):296-304.
2009: Conde Marcus B; Efron Anne; Loredo Carla; De Souza Gilvan R Muzy; Graça Nadja P; Cezar Michelle C; Ram Malathi; Chaudhary Mohammad A; Bishai William R; Kritski Afranio L; Chaisson Richard E
Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial.
Lancet 2009;373(9670):1183-9.
2009: Golub Jonathan E; Pronyk Paul; Mohapi Lerato; Thsabangu Nkeko; Moshabela Mosa; Struthers Helen; Gray Glenda E; McIntyre James A; Chaisson Richard E; Martinson Neil A
Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.
AIDS (London, England) 2009;23(5):631-6.
2009: Cailleaux-Cezar M; de A Melo D; Xavier G M; de Salles C L G; de Mello F C Q; Ruffino-Netto A; Golub J E; Efron A; Chaisson R E; Conde M B
Tuberculosis incidence among contacts of active pulmonary tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2009;13(2):190-5.
2009: Deluca Andrea; Chaisson Richard E; Martinson Neil A
Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: a simple and potentially vital addition for maternal and child health.
Journal of acquired immune deficiency syndromes (1999) 2009;50(2):196-9.
2009: Aguiar F; Vieira M A; Staviack A; Buarque C; Marsico A; Fonseca L; Chaisson R; Kristski A; Werneck G; Mello F
Prevalence of anti-tuberculosis drug resistance in an HIV/AIDS reference hospital in Rio de Janeiro, Brazil.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2009;13(1):54-61.
2009: Ribeiro Samantha; Dooley Kelly; Hackman Judith; Loredo Carla; Efron Anne; Chaisson Richard E; Conde Marcus B; Boechat Neio; Dorman Susan E
T-SPOT.TB responses during treatment of pulmonary tuberculosis.
BMC infectious diseases 2009;9():23.
2008: Golub Jonathan E; Astemborski Jacquie; Ahmed Mohammed; Cronin Wendy; Mehta Shruti H; Kirk Gregory D; Vlahov David; Chaisson Richard E
Long-term effectiveness of diagnosing and treating latent tuberculosis infection in a cohort of HIV-infected and at-risk injection drug users.
Journal of acquired immune deficiency syndromes (1999) 2008;49(5):532-7.
2008: Hoffmann Christopher J; Charalambous Salome; Martin Desmond J; Innes Craig; Churchyard Gavin J; Chaisson Richard E; Grant Alison D; Fielding Katherine L; Thio Chloe L
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(11):1479-85.
2008: Pacheco Antonio G; Saraceni Valeria; Tuboi Suely H; Moulton Lawrence H; Chaisson Richard E; Cavalcante Solange C; Durovni Betina; Faulhaber José C; Golub Jonathan E; King Bonnie; Schechter Mauro; Harrison Lee H
Validation of a hierarchical deterministic record-linkage algorithm using data from 2 different cohorts of human immunodeficiency virus-infected persons and mortality databases in Brazil.
American journal of epidemiology 2008;168(11):1326-32.
2008: Golub Jonathan E; Durovni Betina; King Bonnie S; Cavalacante Solange C; Pacheco Antonio G; Moulton Lawrence H; Moore Richard D; Chaisson Richard E; Saraceni Valeria
Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil.
AIDS (London, England) 2008;22(18):2527-33.
2008: Dooley Kelly; Flexner Charles; Hackman Judith; Peloquin Charles A; Nuermberger Eric; Chaisson Richard E; Dorman Susan E
Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.
Antimicrobial agents and chemotherapy 2008;52(11):4037-42.
2008: Nachega Jean B; Hislop Michael; Dowdy David W; Gallant Joel E; Chaisson Richard E; Regensberg Leon; Maartens Gary
Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.
AIDS (London, England) 2008;22(16):2117-25.
2008: Dowdy David W; Chaisson Richard E; Maartens Gary; Corbett Elizabeth L; Dorman Susan E
Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(32):11293-8.
2008: Charalambous S; Grant A D; Moloi V; Warren R; Day J H; van Helden P; Hayes R J; Fielding K L; De Cock K M; Chaisson R E; Churchyard G J
Contribution of reinfection to recurrent tuberculosis in South African gold miners.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2008;12(8):942-8.
2008: Saraceni V; King B S; Cavalcante S C; Golub J E; Lauria L M; Moulton L H; Chaisson R E; Durovni B
Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2008;12(7):769-72.
2008: Pope Diana S; Deluca Andrea N; Kali Paula; Hausler Harry; Sheard Carol; Hoosain Ebrahim; Chaudhary Mohammad A; Celentano David D; Chaisson Richard E
A cluster-randomized trial of provider-initiated (opt-out) HIV counseling and testing of tuberculosis patients in South Africa.
Journal of acquired immune deficiency syndromes (1999) 2008;48(2):190-5.
2008: Chaisson Richard E; Martinson Neil A
Tuberculosis in Africa--combating an HIV-driven crisis.
The New England journal of medicine 2008;358(11):1089-92.
2008: Pemba L; Charalambous S; von Gottberg A; Magadla B; Moloi V; Seabi O; Wasas A; Klugman K P; Chaisson R E; Fielding K; Churchyard G J; Grant A D
Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa.
The Journal of infection 2008;56(3):171-8.
2008: Hoffmann Christopher J; Fielding Katherine L; Charalambous Salome; Sulkowski Mark S; Innes Craig; Thio Chloe L; Chaisson Richard E; Churchyard Gavin J; Grant Alison D
Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events.
AIDS (London, England) 2008;22(1):67-74.
2008: Dowdy David W; Lourenço Maria C; Cavalcante Solange C; Saraceni Valeria; King Bonnie; Golub Jonathan E; Bishai David; Durovni Betina; Chaisson Richard E; Dorman Susan E
Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults.
PloS one 2008;3(12):e4057.
2008: Pacheco Antonio G; Durovni Betina; Cavalcante Solange C; Lauria L M; Moore Richard D; Moulton Lawrence H; Chaisson Richard E; Golub Jonathan E
AIDS-related tuberculosis in Rio de Janeiro, Brazil.
PloS one 2008;3(9):e3132.
2007: Rosenthal Ian M; Zhang Ming; Williams Kathy N; Peloquin Charles A; Tyagi Sandeep; Vernon Andrew A; Bishai William R; Chaisson Richard E; Grosset Jacques H; Nuermberger Eric L
Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model.
PLoS medicine 2007;4(12):e344.
2007: Schluger Neil; Karunakara Unni; Lienhardt Christian; Nyirenda Thomas; Chaisson Richard
Building clinical trials capacity for tuberculosis drugs in high-burden countries.
PLoS medicine 2007;4(11):e302.
2007: Martinson Neil A; Karstaedt Alan; Venter W D Francois; Omar Tanvier; King Peter; Mbengo Tumi; Marais Else; McIntyre James; Chaisson Richard E; Hale Martin
Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study.
AIDS (London, England) 2007;21(15):2043-50.
2007: Mello Fernanda C Q; Arias Mayra S; Rosales Senia; Marsico Anna Grazia; Pavón Ada; Alvarado-Gálvez Carlos; Pessôa Carlos Leonardo Carvalho; Pérez Melly; Andrade Monica K; Kritski Afranio L; Fonseca Leila S; Chaisson Richard E; Kimerling Michael E; Dorman Susan E
Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin.
Journal of clinical microbiology 2007;45(10):3387-9.
2007: Churchyard Gavin J; Scano Fabio; Grant Alison D; Chaisson Richard E
Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities.
The Journal of infectious diseases 2007;196 Suppl 1():S52-62.
2007: Golub Jonathan E; Saraceni Valeria; Cavalcante Solange C; Pacheco Antonio G; Moulton Lawrence H; King Bonnie S; Efron Anne; Moore Richard D; Chaisson Richard E; Durovni Betina
The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.
AIDS (London, England) 2007;21(11):1441-8.
2007: Hoffmann Christopher J; Charalambous Salome; Thio Chloe L; Martin Desmond J; Pemba Lindiwe; Fielding Katherine L; Churchyard Gavin J; Chaisson Richard E; Grant Alison D
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B.
AIDS (London, England) 2007;21(10):1301-8.
2007: Cavalcante S C; Soares E C C; Pacheco A G F; Chaisson R E; Durovni B;
Community DOT for tuberculosis in a Brazilian favela: comparison with a clinic model.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2007;11(5):544-9.
2007: Nachega Jean B; Hislop Michael; Dowdy David W; Chaisson Richard E; Regensberg Leon; Maartens Gary
Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.
Annals of internal medicine 2007;146(8):564-73.
2007: Dorman Susan E; Chaisson Richard E
From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis.
Nature medicine 2007;13(3):295-8.
2007: Arias Mayra; Mello Fernanda C Q; Pavón Ada; Marsico Anna Grazia; Alvarado-Gálvez Carlos; Rosales Senia; Pessôa Carlos Leonardo Carvalho; Pérez Melly; Andrade Monica K; Kritski Afranio L; Fonseca Leila S; Chaisson Richard E; Kimerling Michael E; Dorman Susan E
Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(5):674-80.
2007: Mohan C I; Bishai D; Cavalcante S; Chaisson R E
The cost-effectiveness of DOTS in urban Brazil.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2007;11(1):27-32.
2007: Charalambous S; Grant A D; Day J H; Pemba L; Chaisson R E; Kruger P; Martin D; Wood R; Brink B; Churchyard G J
Establishing a workplace antiretroviral therapy programme in South Africa.
AIDS care 2007;19(1):34-41.
2007: Moulton Lawrence H; Golub Jonathan E; Durovni Betina; Cavalcante Solange C; Pacheco Antonio G; Saraceni Valeria; King Bonnie; Chaisson Richard E
Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention.
Clinical trials (London, England) 2007;4(2):190-9.
2006: Nachega Jean B; Knowlton Amy R; Deluca Andrea; Schoeman Jan H; Watkinson Linda; Efron Anne; Chaisson Richard E; Maartens Gary
Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study.
Journal of acquired immune deficiency syndromes (1999) 2006;43 Suppl 1():S127-33.
2006: Nachega Jean B; Hislop Michael; Dowdy David W; Lo Melanie; Omer Saad B; Regensberg Leon; Chaisson Richard E; Maartens Gary
Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.
Journal of acquired immune deficiency syndromes (1999) 2006;43(1):78-84.
2006: Burman William J; Goldberg Stefan; Johnson John L; Muzanye Grace; Engle Melissa; Mosher Ann W; Choudhri Shurjeel; Daley Charles L; Munsiff Sonal S; Zhao Zhen; Vernon Andrew; Chaisson Richard E
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis.
American journal of respiratory and critical care medicine 2006;174(3):331-8.
2006: Kali Paula B N; Gray Glenda E; Violari Avy; Chaisson Richard E; McIntyre James A; Martinson Neil A
Combining PMTCT with active case finding for tuberculosis.
Journal of acquired immune deficiency syndromes (1999) 2006;42(3):379-81.
2006: Soares E C C; Pacheco A G F; Mello F C Q; Durovni B; Chaisson R E; Cavalcante S C
Improvements in treatment success rates with directly observed therapy in Rio de Janeiro City.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2006;10(6):690-5.
2006: Sterling T R; Zhao Z; Khan A; Chaisson R E; Schluger N; Mangura B; Weiner M; Vernon A;
Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2006;10(5):542-9.
2006: Schechter Mauro; Zajdenverg Roberto; Falco Gisely; Barnes Grace Link; Faulhaber José Cláudio; Coberly Jacqueline S; Moore Richard D; Chaisson Richard E
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
American journal of respiratory and critical care medicine 2006;173(8):922-6.
2006: Dowdy David W; Chaisson Richard E; Moulton Lawrence H; Dorman Susan E
The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model.
AIDS (London, England) 2006;20(5):751-62.
2006: Lucas Gregory M; Griswold Michael; Gebo Kelly A; Keruly Jeanne; Chaisson Richard E; Moore Richard D
Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.
American journal of epidemiology 2006;163(5):412-20.
2006: Wilson D; Nachega J; Morroni C; Chaisson R; Maartens G
Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2006;10(1):31-8.
2006: Golub J E; Bur S; Cronin W A; Gange S; Baruch N; Comstock G W; Chaisson R E
Delayed tuberculosis diagnosis and tuberculosis transmission.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2006;10(1):24-30.
2006: Mello Fernanda Carvalho de Queiroz; Bastos Luiz Gustavo do Valle; Soares Sérgio Luiz Machado; Rezende Valéria M C; Conde Marcus Barreto; Chaisson Richard E; Kritski Afrânio Lineu; Ruffino-Netto Antonio; Werneck Guilherme Loureiro
Predicting smear negative pulmonary tuberculosis with classification trees and logistic regression: a cross-sectional study.
BMC public health 2006;6():43.
2005: Golub J E; Mohan C I; Comstock G W; Chaisson R E
Active case finding of tuberculosis: historical perspective and future prospects.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(11):1183-203.
2005: Golub J E; Bur S; Cronin W A; Gange S; Baruch N; Comstock G W; Chaisson R E
Patient and health care system delays in pulmonary tuberculosis diagnosis in a low-incidence state.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(9):992-8.
2005: Teixeira E G; Menzies D; Comstock G W; Cunha A J L A; Kritski A L; Soares L C; Bethlem E; Zanetti G; Ruffino-Netto A; Belo M T C T; Selig L; Branco M M Castello; Cherri D; Maia S; Marandino R; Luiz R R; Chaisson R E; Trajman A
Latent tuberculosis infection among undergraduate medical students in Rio de Janeiro State, Brazil.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(8):841-7.
2005: Grant Alison D; Charalambous Salome; Fielding Katherine L; Day John H; Corbett Elizabeth L; Chaisson Richard E; De Cock Kevin M; Hayes Richard J; Churchyard Gavin J
Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.
JAMA : the journal of the American Medical Association 2005;293(22):2719-25.
2005: Golub J E; Bur S; Cronin W A; Gange S; Sterling T R; Oden B; Baruch N; Comstock G W; Chaisson R E
Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(4):392-7.
2005: Wilson D; Nachega J B; Chaisson R E; Maartens G
Diagnostic yield of peripheral lymph node needle-core biopsies in HIV-infected adults with suspected smear-negative tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2005;9(2):220-2.
2005: Nachega Jean B; Lehman Dara A; Hlatshwayo Dorothy; Mothopeng Rachel; Chaisson Richard E; Karstaedt Alan S
HIV/AIDS and antiretroviral treatment knowledge, attitudes, beliefs, and practices in HIV-infected adults in Soweto, South Africa.
Journal of acquired immune deficiency syndromes (1999) 2005;38(2):196-201.
2005: Mehta Shruti H; Thomas David L; Torbenson Michael; Brinkley Sherilyn; Mirel Lisa; Chaisson Richard E; Moore Richard D; Sulkowski Mark S
The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
Hepatology (Baltimore, Md.) 2005;41(1):123-31.
2004: Sulkowski Mark S; Mehta Shruti H; Chaisson Richard E; Thomas David L; Moore Richard D
Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir.
AIDS (London, England) 2004;18(17):2277-84.
2004: Day John H; Grant Alison D; Fielding Katherine L; Morris Lynn; Moloi Victoria; Charalambous Salome; Puren Adrian J; Chaisson Richard E; De Cock Kevin M; Hayes Richard J; Churchyard Gavin J
Does tuberculosis increase HIV load?
The Journal of infectious diseases 2004;190(9):1677-84.
2004: Nuermberger Eric L; Yoshimatsu Tetsuyuki; Tyagi Sandeep; Williams Kathy; Rosenthal Ian; O'Brien Richard J; Vernon Andrew A; Chaisson Richard E; Bishai William R; Grosset Jacques H
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis.
American journal of respiratory and critical care medicine 2004;170(10):1131-4.
2004: Nachega J B; Stein D M; Lehman D A; Hlatshwayo D; Mothopeng R; Chaisson R E; Karstaedt A S
Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa.
AIDS research and human retroviruses 2004;20(10):1053-6.
2004: Karakousis Petros C; Moore Richard D; Chaisson Richard E
Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
The Lancet infectious diseases 2004;4(9):557-65.
2004: Gordin Fred M; Cohn David L; Matts John P; Chaisson Richard E; O'Brien Richard J;
Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(4):561-5.
2004: Boyd Susan J; Thomas-Gosain Neena F; Umbricht Annie; Tucker Marvin J; Leslie Jo M; Chaisson Richard E; Preston Kenzie L
Gender differences in indices of opioid dependency and medical comorbidity in a population of hospitalized HIV-infected African-Americans.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13(3):281-91.
2004: Nuermberger Eric L; Yoshimatsu Tetsuyuki; Tyagi Sandeep; O'Brien Richard J; Vernon Andrew N; Chaisson Richard E; Bishai William R; Grosset Jacques H
Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis.
American journal of respiratory and critical care medicine 2004;169(3):421-6.
2004: Moore Richard D; Keruly Jeanne C; Chaisson Richard E
Differences in HIV disease progression by injecting drug use in HIV-infected persons in care.
Journal of acquired immune deficiency syndromes (1999) 2004;35(1):46-51.
2004: Charalambous S; Grant A D; Day J H; Rothwell E; Chaisson R E; Hayes R J; Churchyard G J
Feasibility and acceptability of a specialist clinical service for HIV-infected mineworkers in South Africa.
AIDS care 2004;16(1):47-56.
2003: Sterling Timothy R; Chaisson Richard E; Keruly Jeanne; Moore Richard D
Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study.
The Journal of infectious diseases 2003;188(11):1659-65.
2003: Benson Constance A; Williams Paige L; Currier Judith S; Holland Fiona; Mahon Laura F; MacGregor Rob Roy; Inderlied Clark B; Flexner Charles; Neidig Judith; Chaisson Richard; Notario Gerard F; Hafner Richard;
A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(9):1234-43.
2003: Chaisson Richard E
Treatment of chronic infections with rifamycins: is resistance likely to follow?
Antimicrobial agents and chemotherapy 2003;47(10):3037-9.
2003: Churchyard Gavin J; Fielding Katherine; Charalambous Salome; Day John H; Corbett Elizabeth L; Hayes Richard J; Chaisson Richard E; De Cock Kevin M; Samb Badara; Grant Alison D
Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?
AIDS (London, England) 2003;17(14):2063-70.
2003: Mehta Shruti H; Moore Richard D; Thomas David L; Chaisson Richard E; Sulkowski Mark S
The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons.
Journal of acquired immune deficiency syndromes (1999) 2003;33(5):577-84.
2003: Pope D S; Chaisson R E
TB treatment: as simple as DOT?
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2003;7(7):611-5.
2003: Lucas Gregory M; Chaisson Richard E; Moore Richard D
Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study.
Journal of acquired immune deficiency syndromes (1999) 2003;33(3):321-8.
2003: Nachega Jean; Coetzee Jennifer; Adendorff Tania; Msandiwa Regina; Gray Glenda E; McIntyre James A; Chaisson Richard E
Tuberculosis active case-finding in a mother-to-child HIV transmission prevention programme in Soweto, South Africa.
AIDS (London, England) 2003;17(9):1398-400.
2003: Morris Lynn; Martin Desmond J; Bredell Helba; Nyoka Stephina N; Sacks Leonard; Pendle Stella; Page-Shipp Liesl; Karp Christopher L; Sterling Timothy R; Quinn Thomas C; Chaisson Richard E
Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients.
The Journal of infectious diseases 2003;187(12):1967-71.
2003: Chaisson Richard E
Tuberculosis chemotherapy: still a double-edged sword.
American journal of respiratory and critical care medicine 2003;167(11):1461-2.
2003: Umbricht Annie; Hoover Donald R; Tucker Marvin J; Leslie Jo M; Chaisson Richard E; Preston Kenzie L
Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
Drug and alcohol dependence 2003;69(3):263-72.
2003: Sterling Timothy R; Chaisson Richard E; Moore Richard D
Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicity.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(6):812-5.
2003: Blumberg Henry M; Burman William J; Chaisson Richard E; Daley Charles L; Etkind Sue C; Friedman Lloyd N; Fujiwara Paula; Grzemska Malgosia; Hopewell Philip C; Iseman Michael D; Jasmer Robert M; Koppaka Venkatarama; Menzies Richard I; O'Brien Richard J; Reves Randall R; Reichman Lee B; Simone Patricia M; Starke Jeffrey R; Vernon Andrew A;
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.
American journal of respiratory and critical care medicine 2003;167(4):603-62.
2003: Nachega Jean B; Chaisson Richard E
Tuberculosis drug resistance: a global threat.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(Suppl 1):S24-30.
2002: Park Walter G; Bishai William R; Chaisson Richard E; Dorman Susan E
Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis.
Journal of clinical microbiology 2002;40(12):4750-2.
2002: Scott Cherise P; Dos Anjos Filho Luciano; De Queiroz Mello Fernanda Carvalho; Thornton Charles G; Bishai William R; Fonseca Leila S; Kritski AfrAnio L; Chaisson Richard E; Manabe Yukari C
Comparison of C(18)-carboxypropylbetaine and standard N-acetyl-L-cysteine-NaOH processing of respiratory specimens for increasing tuberculosis smear sensitivity in Brazil.
Journal of clinical microbiology 2002;40(9):3219-22.
2002: Benator Debra; Bhattacharya Mondira; Bozeman Lorna; Burman William; Cantazaro Antonino; Chaisson Richard; Gordin Fred; Horsburgh C Robert; Horton James; Khan Awal; Lahart Christopher; Metchock Beverly; Pachucki Constance; Stanton Llewellyn; Vernon Andrew; Villarino M Elsa; Wang Yong Chen; Weiner Marc; Weis Stephen;
Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial.
Lancet 2002;360(9332):528-34.
2002: Chaisson Richard E; Gebo Kelly; Flexner Charles; Gallant Joel E; Lucas Gregory M; Bartlett John G
Selected topics from the 9th Conference on Retroviruses and Opportunistic Infections.
HIV clinical trials 2002;3(4):333-49.
2002: Sulkowski Mark S; Moore Richard D; Mehta Shruti H; Chaisson Richard E; Thomas David L
Hepatitis C and progression of HIV disease.
JAMA : the journal of the American Medical Association 2002;288(2):199-206.
2002: Chaisson Richard E; Armstrong Joan; Stafford John; Golub Jonathan; Bur Sarah
Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners.
JAMA : the journal of the American Medical Association 2002;288(2):165-6.
2002: Gounder Celine; De Queiroz Mello Fernanda Carvalho; Conde Marcus B; Bishai William R; Kritski Afrânio L; Chaisson Richard E; Dorman Susan E
Field evaluation of a rapid immunochromatographic test for tuberculosis.
Journal of clinical microbiology 2002;40(6):1989-93.
2002: Yoshimatsu Tetsuyuki; Nuermberger Eric; Tyagi Sandeep; Chaisson Richard; Bishai William; Grosset Jacques
Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.
Antimicrobial agents and chemotherapy 2002;46(6):1875-9.
2002: Bellete Bahrie; Coberly Jacqueline; Barnes Grace Link; Ko Chiew; Chaisson Richard E; Comstock George W; Bishai William R
Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(11):1449-56.
2002: Chaisson Richard E
TB and HIV: challenges and progress.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 2002;14(3):8-9.
2002: Gillini Laura Aian; Cingolani Antonella; Murri Rita; De Luca Andrea; Di Giambenedetto Simona; Wu Albert; Cauda Roberto; Chaisson Richard E
Declining tuberculosis and drug resistance rate among HIV-positive patients at an Italian teaching hospital in the era of highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2002;29(5):546-7.
2002: Lucas Gregory M; Gebo Kelly A; Chaisson Richard E; Moore Richard D
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.
AIDS (London, England) 2002;16(5):767-74.
2002: Riley Elise D; Vlahov David; Huettner Steven; Beilenson Peter; Bonds Margaret; Chaisson Richard E
Characteristics of injection drug users who utilize tuberculosis services at sites of the Baltimore city needle exchange program.
Journal of urban health : bulletin of the New York Academy of Medicine 2002;79(1):113-27.
2002: Oursler Kris K; Moore Richard D; Bishai William R; Harrington Susan M; Pope Diana S; Chaisson Richard E
Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(6):752-9.
2002: Sulkowski Mark S; Thomas David L; Mehta Shruti H; Chaisson Richard E; Moore Richard D
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.
Hepatology (Baltimore, Md.) 2002;35(1):182-9.
2002: D'Lugoff Marion Isaacs; Jones Walt; Kub Joan; Glass Nancy; Thompson Deidre; Brinkley-Laughon Sherilynn; Chaisson Richard E
Tuberculosis screening in an at-risk immigrant Hispanic population in Baltimore city: an academic health center/local health department partnership.
Journal of cultural diversity 2002;9(3):79-85.
2001: Sterling T R; Chaisson R E; Moore R D
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
AIDS (London, England) 2001;15(17):2251-7.
2001: Golub J E; Cronin W A; Obasanjo O O; Coggin W; Moore K; Pope D S; Thompson D; Sterling T R; Harrington S; Bishai W R; Chaisson R E
Transmission of Mycobacterium tuberculosis through casual contact with an infectious case.
Archives of internal medicine 2001;161(18):2254-8.
2001: Sterling T R; Dorman S E; Chaisson R E; Ding L; Hackman J; Moore K; Holland S M
Human immunodeficiency virus-seronegative adults with extrapulmonary tuberculosis have abnormal innate immune responses.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(7):976-82.
2001: Keruly J C; Chaisson R E; Moore R D
Increasing incidence of avascular necrosis of the hip in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2001;28(1):101-2.
2001: Lucas G M; Chaisson R E; Moore R D
Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz.
AIDS (London, England) 2001;15(13):1679-86.
2001: Chaisson R E
AIDS turns 20: reflections on a brief but extraordinary history.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 2001;13(4):1, 5.
2001: Lucas G M; Cheever L W; Chaisson R E; Moore R D
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2001;27(3):251-9.
2001: Wendel K A; Alwood K S; Gachuhi R; Chaisson R E; Bishai W R; Sterling T R
Paradoxical worsening of tuberculosis in HIV-infected persons.
Chest 2001;120(1):193-7.
2001: Riley E D; Chaisson R E; Robnett T J; Vertefeuille J; Strathdee S A; Vlahov D
Use of audio computer-assisted self-interviews to assess tuberculosis-related risk behaviors.
American journal of respiratory and critical care medicine 2001;164(1):82-5.
2001: Poundstone K E; Chaisson R E; Moore R D
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy.
AIDS (London, England) 2001;15(9):1115-23.
2001: Chaisson R E; Barnes G L; Hackman J; Watkinson L; Kimbrough L; Metha S; Cavalcante S; Moore R D
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.
The American journal of medicine 2001;110(8):610-5.
2001: Moore R D; Keruly J C; Chaisson R E
Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs.
AIDS (London, England) 2001;15(5):617-20.
2001: Obasanjo O O; Wu P; Conlon M; Karanfil L V; Pryor P; Moler G; Anhalt G; Chaisson R E; Perl T M
An outbreak of scabies in a teaching hospital: lessons learned.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2001;22(1):13-8.
2000: Bishai W; Brueggemann A B; Nicolau D P; Steinberg I; Spiritus E; Tanigawa C; Koenig S; Chaisson R E; Browne B A; Yoder D M
Roundtable discussion. Optimizing the use of antimicrobial therapy.
The American journal of managed care 2000;6(23 Suppl):S1222-35.
2000: Chaisson R E
Guidelines for the management of community-acquired pneumonia.
The American journal of managed care 2000;6(23 Suppl):S1211-5.
2000: Chaisson R E
New developments in the treatment of latent tuberculosis.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2000;4(12 Suppl 2):S176-81.
2000: Chaisson R E; Keruly J C; Moore R D
Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy.
JAMA : the journal of the American Medical Association 2000;284(24):3128-9.
2000: Stringer J S; Youle M; Sabin C; Chaisson R E; Sterling T R
Selected topics from the 13th International AIDS Conference, July 9-14, 2000. Duran, South Africa.
HIV clinical trials 2000;1(3):100-11.
2000: Sterling T R; Thompson D; Stanley R L; McElroy P D; Madison A; Moore K; Ridzon R; Harrington S; Bishai W R; Chaisson R E; Bur S
A multi-state outbreak of tuberculosis among members of a highly mobile social network: implications for tuberculosis elimination.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2000;4(11):1066-73.
2000: Chaisson R E; Sterling T R
Opportunistic infections.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 2000;12(4):10, 16.
2000: Chaisson R E
The world AIDS conference in Durban, South Africa--science, politics, and health.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 2000;12(4):1, 6-7.
2000: Sullivan J H; Moore R D; Keruly J C; Chaisson R E
Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection.
American journal of respiratory and critical care medicine 2000;162(1):64-7.
2000: Chaisson R E; Bartlett J G
Update on opportunistic infections.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 2000;12(2):3, 10, 15.
2000: Gordin F; Chaisson R E; Matts J P; Miller C; de Lourdes Garcia M; Hafner R; Valdespino J L; Coberly J; Schechter M; Klukowicz A J; Barry M A; O'Brien R J
Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group.
JAMA : the journal of the American Medical Association 2000;283(11):1445-50.
2000: Rao S N; Mookerjee A L; Obasanjo O O; Chaisson R E
Errors in the treatment of tuberculosis in Baltimore.
Chest 2000;117(3):734-7.
2000: Sterling T R; Pope D S; Bishai W R; Harrington S; Gershon R R; Chaisson R E
Transmission of Mycobacterium tuberculosis from a cadaver to an embalmer.
The New England journal of medicine 2000;342(4):246-8.
2000: Sulkowski M S; Thomas D L; Chaisson R E; Moore R D
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.
JAMA : the journal of the American Medical Association 2000;283(1):74-80.
1999: Moore R D; Chaisson R E
Natural history of HIV infection in the era of combination antiretroviral therapy.
AIDS (London, England) 1999;13(14):1933-42.
1999: Sterling T R; Alwood K; Gachuhi R; Coggin W; Blazes D; Bishai W R; Chaisson R E
Relapse rates after short-course (6-month) treatment of tuberculosis in HIV-infected and uninfected persons.
AIDS (London, England) 1999;13(14):1899-904.
1999: Miyazaki E; Chaisson R E; Bishai W R
Analysis of rifapentine for preventive therapy in the Cornell mouse model of latent tuberculosis.
Antimicrobial agents and chemotherapy 1999;43(9):2126-30.
1999: Chaisson R E
HIV becomes world's leading infectious cause of death.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 1999;11(4):1.
1999: Lucas G M; Chaisson R E; Moore R D
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.
Annals of internal medicine 1999;131(2):81-7.
1999: Corbett E L; Blumberg L; Churchyard G J; Moloi N; Mallory K; Clayton T; Williams B G; Chaisson R E; Hayes R J; De Cock K M
Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners.
American journal of respiratory and critical care medicine 1999;160(1):15-21.
1999: De Cock K M; Chaisson R E
Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1999;3(6):457-65.
1999: Chaisson R E
Update on treatment and prevention guidelines for HIV-related tuberculosis.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 1999;11(3):3,10,12.
1999: Gebo K A; Chaisson R E; Folkemer J G; Bartlett J G; Moore R D
Costs of HIV medical care in the era of highly active antiretroviral therapy.
AIDS (London, England) 1999;13(8):963-9.
1999: Oursler K A; Moore R D; Chaisson R E
Risk factors for cryptococcal meningitis in HIV-infected patients.
AIDS research and human retroviruses 1999;15(7):625-31.
1999: Finzi D; Blankson J; Siliciano J D; Margolick J B; Chadwick K; Pierson T; Smith K; Lisziewicz J; Lori F; Flexner C; Quinn T C; Chaisson R E; Rosenberg E; Walker B; Gange S; Gallant J; Siliciano R F
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.
Nature medicine 1999;5(5):512-7.
1999: Kimura M; Converse P J; Astemborski J; Rothel J S; Vlahov D; Comstock G W; Graham N M; Chaisson R E; Bishai W R
Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure.
The Journal of infectious diseases 1999;179(5):1297-300.
1999: Bishai W R; Chaisson R E
Opportunistic infections: down but not out.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 1999;11(2):2, 7, 12.
1999: Sterling T R; Brehm W T; Moore R D; Chaisson R E
Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1999;3(3):248-54.
1999: Gallant J E; Chaisson R E; Keruly J C; Moore R D
Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients.
AIDS (London, England) 1999;13(2):225-9.
1999: Moore R D; Cheever L; Keruly J C; Chaisson R E
Lack of sex difference in CD4 to HIV-1 RNA viral load ratio.
Lancet 1999;353(9151):463-4.
1999: Chaisson R E; Coberly J S; De Cock K M
DOTS and drug resistance: a silver lining to a darkening cloud.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1999;3(1):1-3.
1999: Miyazaki E; Miyazaki M; Chen J M; Chaisson R E; Bishai W R
Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis.
Antimicrobial agents and chemotherapy 1999;43(1):85-9.
1998: Sulkowski M S; Chaisson R E; Karp C L; Moore R D; Margolick J B; Quinn T C
The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults.
The Journal of infectious diseases 1998;178(6):1642-8.
1998: Chaisson R E; Bishai W
No news is good news: opportunistic infections.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 1998;10(6):2, 11.
1998: Bishai W R; Graham N M; Harrington S; Pope D S; Hooper N; Astemborski J; Sheely L; Vlahov D; Glass G E; Chaisson R E
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy.
JAMA : the journal of the American Medical Association 1998;280(19):1679-84.
1998: Gallant J E; Chaisson R E; Moore R D
The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications.
Chest 1998;114(5):1258-63.
1998: Morris L; Martin D J; Quinn T C; Chaisson R E
The importance of doing HIV research in developing countries.
Nature medicine 1998;4(11):1228-9.
1998: Manabe Y C; Clark D P; Moore R D; Lumadue J A; Dahlman H R; Belitsos P C; Chaisson R E; Sears C L
Cryptosporidiosis in patients with AIDS: correlates of disease and survival.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(3):536-42.
1998: Moore R D; Keruly J C; Chaisson R E
Anemia and survival in HIV infection.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(1):29-33.
1998: Halsey N A; Coberly J; Chaisson R
Prevention of tuberculosis in HIV-1.
Lancet 1998;352(9129):742.
1998: Sterling T R; Moore R D; Graham N M; Astemborski J; Vlahov D; Chaisson R E
Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease.
AIDS (London, England) 1998;12(12):1451-7.
1998: Eldred L J; Wu A W; Chaisson R E; Moore R D
Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;18(2):117-25.
1998: Chaisson R E
Short course preventive therapy for tuberculosis is successful in HIV-infected patients.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 1998;10(3):2-3.
1998: Halsey N A; Coberly J S; Desormeaux J; Losikoff P; Atkinson J; Moulton L H; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson R E
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.
Lancet 1998;351(9105):786-92.
1998: Chaisson R E; Gallant J E; Keruly J C; Moore R D
Impact of opportunistic disease on survival in patients with HIV infection.
AIDS (London, England) 1998;12(1):29-33.
1997: Finzi D; Hermankova M; Pierson T; Carruth L M; Buck C; Chaisson R E; Quinn T C; Chadwick K; Margolick J; Brookmeyer R; Gallant J; Markowitz M; Ho D D; Richman D D; Siliciano R F
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.
Science (New York, N.Y.) 1997;278(5341):1295-300.
1997: Michele T M; Cronin W A; Graham N M; Dwyer D M; Pope D S; Harrington S; Chaisson R E; Bishai W R
Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope. Identification by DNA fingerprinting.
JAMA : the journal of the American Medical Association 1997;278(13):1093-5.
1997: Moore R D; Chaisson R E
Cost-utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(1):15-21.
1997: Styrt B A; Chaisson R E; Moore R D
Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients.
AIDS (London, England) 1997;11(10):1243-8.
1997: Gielen A C; Faden R R; Kass N E; O'Campo P; Chaisson R; Watkinson L
Evaluation of an HIV/AIDS education program in an urban prenatal clinic.
Women's health issues : official publication of the Jacobs Institute of Women's Health 1997;7(4):269-78.
1997: Erbelding E J; Chaisson R E; Gallant J E; Moore R D
Acyclovir in combination with zidovudine does not prolong survival in advanced HIV disease.
Antiviral therapy 1997;2(2):71-7.
1997: Chaisson R E; Keiser P; Pierce M; Fessel W J; Ruskin J; Lahart C; Benson C A; Meek K; Siepman N; Craft J C
Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection.
AIDS (London, England) 1997;11(3):311-7.
1997: Moore R D; Chaisson R E
Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;14(3):223-31.
1997: Bishai W R; Chaisson R E
Short-course chemoprophylaxis for tuberculosis.
Clinics in chest medicine 1997;18(1):115-22.
1997: Chaisson R E; Moore R D
Prevention of opportunistic infections in the era of improved antiretroviral therapy.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16 Suppl 1():S14-22.
1996: Chaisson R E; Clermont H C; Holt E A; Cantave M; Johnson M P; Atkinson J; Davis H; Boulos R; Quinn T C; Halsey N A
Six-month supervised intermittent tuberculosis therapy in Haitian patients with and without HIV infection.
American journal of respiratory and critical care medicine 1996;154(4 Pt 1):1034-8.
1996: Moore R D; Chaulk C P; Griffiths R; Cavalcante S; Chaisson R E
Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis.
American journal of respiratory and critical care medicine 1996;154(4 Pt 1):1013-9.
1996: Cheever L W; Chaisson R E; Gallant J E
Prophylaxis against opportunistic infections in patients infected with the human immunodeficiency virus.
The Western journal of medicine 1996;165(1-2):67-73.
1996: Moore R D; Fortgang I; Keruly J; Chaisson R E
Adverse events from drug therapy for human immunodeficiency virus disease.
The American journal of medicine 1996;101(1):34-40.
1996: Bishai W R; Graham N M; Harrington S; Page C; Moore-Rice K; Hooper N; Chaisson R E
Brief report: rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis.
The New England journal of medicine 1996;334(24):1573-6.
1996: Moore R D; Keruly J C; Chaisson R E
Duration of the survival benefit of zidovudine therapy in HIV infection.
Archives of internal medicine 1996;156(10):1073-7.
1996: Chaisson R E
Potential role of rifabutin in prophylaxis for tuberculosis and infections due to multiple opportunistic pathogens.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22 Suppl 1():S61-6; discussion S66-9.
1996: Moore R D; Chaisson R E
Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
Annals of internal medicine 1996;124(7):633-42.
1996: Chaisson R E; Keruly J C; McAvinue S; Gallant J E; Moore R D
Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(5):455-9.
1996: Gebo K A; Moore R D; Keruly J C; Chaisson R E
Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 1996;173(4):857-62.
1996: Desormeaux J; Johnson M P; Coberly J S; Losikoff P; Johnson E; Huebner R; Geiter L; Davis H; Atkinson J; Chaisson R E; Boulos R; Halsey N A
Widespread HIV counseling and testing linked to a community-based tuberculosis control program in a high-risk population.
Bulletin of the Pan American Health Organization 1996;30(1):1-8.
1996: Janis E M; Allen D W; Glesby M J; Carey L A; Mundy L M; Gopalan R; Chaisson R E
Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Longcope Firm of the Osler Medical Housestaff.
The American journal of medicine 1996;100(2):186-92.
1996: Maenza J R; Keruly J C; Moore R D; Chaisson R E; Merz W G; Gallant J E
Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 1996;173(1):219-25.
1995: Moore R D; Chaisson R E
Survival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS.
AIDS (London, England) 1995;9(12):1337-42.
1995: Moore R D; Keruly J C; Chaisson R E
Neutropenia and bacterial infection in acquired immunodeficiency syndrome.
Archives of internal medicine 1995;155(18):1965-70.
1995: Chaulk C P; Moore-Rice K; Rizzo R; Chaisson R E
Eleven years of community-based directly observed therapy for tuberculosis.
JAMA : the journal of the American Medical Association 1995;274(12):945-51.
1995: Fortgang I S; Belitsos P C; Chaisson R E; Moore R D
Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy.
The American journal of gastroenterology 1995;90(9):1433-6.
1995: Chaisson R E; Keruly J C; Moore R D
Race, sex, drug use, and progression of human immunodeficiency virus disease.
The New England journal of medicine 1995;333(12):751-6.
1995: Chaisson R E
Mycobacterium avium complex and HIV.
Journal of the International Association of Physicians in AIDS Care 1995;1(7):10-5.
1995: Glesby M J; Moore R D; Chaisson R E
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(2):370-5.
1995: Gallant J E; Moore R D; Keruly J; Richman D D; Chaisson R E
Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
The Journal of infectious diseases 1995;172(2):346-52.
1995: Chaisson R E
Mycobacterial infections and HIV.
Kekkaku : [Tuberculosis] 1995;70(4):313-20.
1995: Gallant J E; McAvinue S M; Moore R D; Bartlett J G; Stanton D L; Chaisson R E
The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia.
Chest 1995;107(4):1018-23.
1995: Barditch-Crovo P; Chaisson R E
Adverse reactions to therapy for HIV infection.
Emergency medicine clinics of North America 1995;13(1):133-46.
1994: Chaisson R E; Benson C A; Dube M P; Heifets L B; Korvick J A; Elkin S; Smith T; Craft J C; Sattler F R
Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.
Annals of internal medicine 1994;121(12):905-11.
1994: Moore R D; Chaisson R E; Hidalgo J
The efficacy of zidovudine is time limited.
JAMA : the journal of the American Medical Association 1994;272(13):1001; author reply 1001-2.
1994: Stanton D L; Wu A W; Moore R D; Rucker S C; Piazza M P; Abrams J E; Chaisson R E
Functional status of persons with HIV infection in an ambulatory setting.
Journal of acquired immune deficiency syndromes 1994;7(10):1050-6.
1994: Chaisson R E
Smoking cessation in patients with HIV.
JAMA : the journal of the American Medical Association 1994;272(7):564.
1994: Alwood K; Keruly J; Moore-Rice K; Stanton D L; Chaulk C P; Chaisson R E
Effectiveness of supervised, intermittent therapy for tuberculosis in HIV-infected patients.
AIDS (London, England) 1994;8(8):1103-8.
1994: Gallant J E; Moore R D; Chaisson R E
Prophylaxis for opportunistic infections in patients with HIV infection.
Annals of internal medicine 1994;120(11):932-44.
1994: Moore R D; Hidalgo J; Bareta J C; Chaisson R E
Zidovudine therapy and health resource utilization in AIDS.
Journal of acquired immune deficiency syndromes 1994;7(4):349-54.
1994: Gallant J E; Moore R D; Richman D D; Keruly J; Chaisson R E
Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Archives of internal medicine 1994;154(5):566-72.
1994: Moore R D; Stanton D; Gopalan R; Chaisson R E
Racial differences in the use of drug therapy for HIV disease in an urban community.
The New England journal of medicine 1994;330(11):763-8.
1994: Chaulk C P; Chaisson R E; Lewis J N; Rizzo R T
Treating multidrug-resistant tuberculosis: compliance and side effects.
JAMA : the journal of the American Medical Association 1994;271(2):103-4; author reply 105.
1994: Faden Ruth R; Gielen Andrea C; Kass Nancy; O'Campo Patricia; Anderson Jean; Chaisson Richard; Sheon Amy
Prenatal HIV-antibody testing and the meaning of consent.
AIDS & public policy journal 1994;9(3):151-9.
1994: Small P M; Hopewell P C; Schecter G F; Chaisson R E; Goodman P C
Evolution of chest radiographs in treated patients with pulmonary tuberculosis and HIV infection.
Journal of thoracic imaging 1994;9(2):74-7.
1993: Graham N M; Chaisson R E
Tuberculosis and HIV infection: epidemiology, pathogenesis, and clinical aspects.
Annals of allergy 1993;71(5):421-8; quiz 428-33.
1993: Glesby M J; Moore R D; Chaisson R E
Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group.
The Journal of infectious diseases 1993;168(5):1264-8.
1993: Gallant J E; Eldred L J; Leslie J M; Chaisson R E; Quinn T C
Impact of the 1993 revision of the CDC case definition on the performance of the WHO and PAHO clinical case definitions for AIDS.
AIDS (London, England) 1993;7(10):1396-7.
1993: Nightingale S D; Cameron D W; Gordin F M; Sullam P M; Cohn D L; Chaisson R E; Eron L J; Sparti P D; Bihari B; Kaufman D L
Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.
The New England journal of medicine 1993;329(12):828-33.
1993: McDiarmid M A; Fujikawa J; Schaefer J; Weinmann G; Chaisson R E; Hudson C A
Health effects and exposure assessment of aerosolized pentamidine handlers.
Chest 1993;104(2):382-5.
1993: Cotton D J; Powderly W G; Feinberg J; Abrams D I; Chaisson R E; Wheat L J; Finkelstein D M; Tallman V; Zimmer B; Berzon R
Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;16(6):816-22; discussion 823-4.
1993: Chaisson R E; Stanton D L; Gallant J E; Rucker S; Bartlett J G; Moore R D
Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting.
AIDS (London, England) 1993;7(6):857-62.
1993: Herskowitz A; Vlahov D; Willoughby S; Chaisson R E; Schulman S P; Neumann D A; Baughman K L
Prevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infection.
The American journal of cardiology 1993;71(11):955-8.
1993: Johnson M P; Chaisson R E
Tuberculosis and HIV disease.
AIDS clinical review 1993;():73-93.
1992: Nordback I H; Olson J L; Chaisson R E; Cameron J L
Acute effects of a nucleoside analog dideoxyinosine (DDI) on the pancreas.
The Journal of surgical research 1992;53(6):610-4.
1992: Chaisson R
Clarithromycin is effective against M. avium complex in AIDS.
American family physician 1992;46(6):1784.
1992: McDiarmid M A; Schaefer J; Richard C L; Chaisson R E; Tepper B S
Efficacy of engineering controls in reducing occupational exposure to aerosolized pentamidine.
Chest 1992;102(6):1764-6.
1992: Gallant J E; Moore R D; Richman D D; Keruly J; Chaisson R E
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
The Journal of infectious diseases 1992;166(6):1223-7.
1992: Galai N; Graham N; Chaisson R; Nelson K E; Vlahov D; Lewis J
Multidrug-resistant tuberculosis.
The New England journal of medicine 1992;327(16):1172-3; author reply 1174.
1992: Chaisson R E; Keruly J; Richman D D; Moore R D
Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Archives of internal medicine 1992;152(10):2009-13.
1992: O'Campo P; de Boer M A; Faden R R; Gielen A C; Kass N; Chaisson R
Discrepancies between women's personal interview data and medical record documentation of illicit drug use, sexually transmitted diseases, and HIV infection.
Medical care 1992;30(10):965-71.
1992: Gallant J E; Mueller P S; McArthur J C; Chaisson R E
Intramedullary tuberculoma in a patient with HIV infection.
AIDS (London, England) 1992;6(8):889-91.
1992: Chaisson R E; Moore R D; Richman D D; Keruly J; Creagh T
Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
The American review of respiratory disease 1992;146(2):285-9.
1992: Johnson M P; Coberly J S; Clermont H C; Chaisson R E; Davis H L; Losikoff P; Ruff A J; Boulos R; Halsey N A
Tuberculin skin test reactivity among adults infected with human immunodeficiency virus.
The Journal of infectious diseases 1992;166(1):194-8.
1992: Moore R D; Keruly J; Richman D D; Creagh-Kirk T; Chaisson R E
Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
AIDS (London, England) 1992;6(7):671-7.
1992: Samuels J F; Vlahov D; Anthony J C; Chaisson R E
Measurement of HIV risk behaviors among intravenous drug users.
British journal of addiction 1992;87(3):417-28.
1992: Gallant J E; Somani J; Chaisson R E; Stanton D; Smith M; Quinn T C
Diagnostic accuracy of three clinical case definitions for advanced HIV disease.
AIDS (London, England) 1992;6(3):295-9.
1992: Chaisson R E; Taylor E; Margolick J B; Muñoz A; Solomon L; Cohn S; Nelson K E; Vlahov D
Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.
Journal of acquired immune deficiency syndromes 1992;5(5):456-60.
1991: Flexner C; Barditch-Crovo P A; Kornhauser D M; Farzadegan H; Nerhood L J; Chaisson R E; Bell K M; Lorentsen K J; Hendrix C W; Petty B G
Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection.
Antimicrobial agents and chemotherapy 1991;35(12):2544-50.
1991: Steinhoff M C; Auerbach B S; Nelson K E; Vlahov D; Becker R L; Graham N M; Schwartz D H; Lucas A H; Chaisson R E
Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection.
The New England journal of medicine 1991;325(26):1837-42.
1991: Easterbrook P J; Keruly J C; Creagh-Kirk T; Richman D D; Chaisson R E; Moore R D
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.
JAMA : the journal of the American Medical Association 1991;266(19):2713-8.
1991: Chaisson R E; McAvinue S
Control of tuberculosis during aerosol therapy administration.
Respiratory care 1991;36(9):1017-25.
1991: Lee B L; Padula A M; Kimbrough R C; Jones S R; Chaisson R E; Mills J; Sande M A
Infectious complications with respiratory pathogens despite ciprofloxacin therapy.
The New England journal of medicine 1991;325(7):520-1.
1991: Feigal E; Murphy E; Vranizan K; Bacchetti P; Chaisson R; Drummond J E; Blattner W; McGrath M; Greenspan J; Moss A
Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.
The Journal of infectious diseases 1991;164(1):36-42.
1991: Small P M; Schecter G F; Goodman P C; Sande M A; Chaisson R E; Hopewell P C
[HIV infection and tuberculosis]
Deutsche medizinische Wochenschrift (1946) 1991;116(23):919.
1991: Moore R D; Hidalgo J; Sugland B W; Chaisson R E
Zidovudine and the natural history of the acquired immunodeficiency syndrome.
The New England journal of medicine 1991;324(20):1412-6.
1991: Moore R D; Kessler H; Richman D D; Flexner C; Chaisson R E
Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine.
JAMA : the journal of the American Medical Association 1991;265(17):2208-11.
1991: Moore R D; Creagh-Kirk T; Keruly J; Link G; Wang M C; Richman D; Chaisson R E
Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group.
Archives of internal medicine 1991;151(5):981-6.
1991: Levine B; Chaisson R E
Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.
Annals of internal medicine 1991;114(10):861-8.
1991: Barbacci M; Repke J T; Chaisson R E
HIV testing urged for pregnancy.
Nursing times 1991;87(14):11.
1991: Barbacci M; Repke J T; Chaisson R E
Routine prenatal screening for HIV infection.
Lancet 1991;337(8743):709-11.
1991: Chaisson R E; Fuchs E; Stanton D L; Quinn T C; Hendricksen C; Bartlett J G; Farzadegan H
Racial heterogeneity of HIV antigenemia in people with HIV infection.
AIDS (London, England) 1991;5(2):177-80.
1991: Small P M; Schecter G F; Goodman P C; Sande M A; Chaisson R E; Hopewell P C
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.
The New England journal of medicine 1991;324(5):289-94.
1991: Jacobson M A; Bacchetti P; Kolokathis A; Chaisson R E; Szabo S; Polsky B; Valainis G T; Mildvan D; Abrams D; Wilber J
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.
BMJ (Clinical research ed.) 1991;302(6768):73-8.
1991: Hendrix C W; Volberding P A; Chaisson R E
HIV antigen variability in ARC/AIDS.
Journal of acquired immune deficiency syndromes 1991;4(9):847-50.
1991: Johnson M P; Chaisson R E
Tuberculosis and HIV disease.
AIDS clinical review 1991;():109-26.
1990: Ng V L; Virani N A; Chaisson R E; Yajko D M; Sphar H T; Cabrian K; Rollins N; Charache P; Krieger M; Hadley W K
Rapid detection of Pneumocystis carinii using a direct fluorescent monoclonal antibody stain.
Journal of clinical microbiology 1990;28(10):2228-33.
1990: Chaisson R E; Griffin D E
Progressive multifocal leukoencephalopathy in AIDS.
JAMA : the journal of the American Medical Association 1990;264(1):79-82.
1990: Barbacci M B; Dalabetta G A; Repke J T; Talbot B L; Charache P; Polk B F; Chaisson R E
Human immunodeficiency virus infection in women attending an inner-city prenatal clinic: ineffectiveness of targeted screening.
Sexually transmitted diseases 1990;17(3):122-6.
1990: Theuer C P; Hopewell P C; Elias D; Schecter G F; Rutherford G W; Chaisson R E
Human immunodeficiency virus infection in tuberculosis patients.
The Journal of infectious diseases 1990;162(1):8-12.
1990: Chaisson R E; Smith M D
Pneumocystis carinii pneumonia: diagnosis and management.
Maryland medical journal (Baltimore, Md. : 1985) 1990;39(4):365-9.
1990: Lemp G F; Payne S F; Rutherford G W; Hessol N A; Winkelstein W; Wiley J A; Moss A R; Chaisson R E; Chen R T; Feigal D W
Projections of AIDS morbidity and mortality in San Francisco.
JAMA : the journal of the American Medical Association 1990;263(11):1497-501.
1990: Chaisson R E
Prevention of opportunistic infections in patients with HIV.
Maryland medical journal (Baltimore, Md. : 1985) 1990;39(2):156-60.
1990: Chaisson R E
Living with AIDS.
JAMA : the journal of the American Medical Association 1990;263(3):434-6.
1989: Chaisson R E
Tuberculosis and HIV infection--new opportunities for an old pathogen.
The Western journal of medicine 1989;150(6):687-9.
1989: Jacobson M A; Abrams D I; Volberding P A; Bacchetti P; Wilber J; Chaisson R E; Crowe S; Howard W; Moss A
Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine.
The Journal of infectious diseases 1989;159(6):1029-36.
1989: Chaisson R E
Bacterial pneumonia in patients with human immunodeficiency virus infection.
Seminars in respiratory infections 1989;4(2):133-8.
1989: Chaisson R E; Hopewell P C
Mycobacteria and AIDS mortality.
The American review of respiratory disease 1989;139(1):1-3.
1989: Chaisson R E; Bacchetti P; Osmond D; Brodie B; Sande M A; Moss A R
Cocaine use and HIV infection in intravenous drug users in San Francisco.
JAMA : the journal of the American Medical Association 1989;261(4):561-5.
1989: Chaisson R E; Slutkin G
Tuberculosis and human immunodeficiency virus infection.
The Journal of infectious diseases 1989;159(1):96-100.
1988: Chaisson R E; Leuther M D; Allain J P; Nusinoff-Lehrman S; Boone G S; Feigal D; Volberding P
Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.
Archives of internal medicine 1988;148(10):2151-3.
1988: Osmond D; Bacchetti P; Chaisson R E; Kelly T; Stempel R; Carlson J; Moss A R
Time of exposure and risk of HIV infection in homosexual partners of men with AIDS.
American journal of public health 1988;78(8):944-8.
1988: Chaisson R E
Infections due to encapsulated bacteria, Salmonella, Shigella, and Campylobacter.
Infectious disease clinics of North America 1988;2(2):475-84.
1988: Bacchetti P; Osmond D; Chaisson R E; Dritz S; Rutherford G W; Swig L; Moss A R
Survival patterns of the first 500 patients with AIDS in San Francisco.
The Journal of infectious diseases 1988;157(5):1044-7.
1988: Moss A R; Bacchetti P; Osmond D; Krampf W; Chaisson R E; Stites D; Wilber J; Allain J P; Carlson J
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.
British medical journal (Clinical research ed.) 1988;296(6624):745-50.
1988: Rosenthal P J; Chaisson R E; Hadley W K; Leech J H
Rectal leishmaniasis in a patient with acquired immunodeficiency syndrome.
The American journal of medicine 1988;84(2):307-9.
1987: Celum C L; Chaisson R E; Rutherford G W; Barnhart J L; Echenberg D F
Incidence of salmonellosis in patients with AIDS.
The Journal of infectious diseases 1987;156(6):998-1002.
1987: Chaisson R E; Hopewell P C
Empiric diagnosis of Pneumocystis pneumonia.
JAMA : the journal of the American Medical Association 1987;258(23):3385.
1987: Leoung G S; Chaisson R E; Mills J
Comparison of nosocomial infections due to Staphylococcus aureus and enterococci in a general hospital.
Surgery, gynecology & obstetrics 1987;165(4):339-42.
1987: Chaisson R E; Schecter G F; Theuer C P; Rutherford G W; Echenberg D F; Hopewell P C
Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival.
The American review of respiratory disease 1987;136(3):570-4.
1987: Osmond D; Chaisson R; Moss A; Bacchetti P; Krampf W
Lymphadenopathy in asymptomatic patients seropositive for HIV.
The New England journal of medicine 1987;317(4):246.
1987: Chaisson R E; Osmond D; Moss A R; Feldman H W; Bernacki P
HIV, bleach, and needle sharing.
Lancet 1987;1(8547):1430.
1987: Chaisson R E; Moss A R; Onishi R; Osmond D; Carlson J R
Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco.
American journal of public health 1987;77(2):169-72.
1986: Chaisson R E; Allain J P; Leuther M; Volberding P A
Significant changes in HIV antigen level in the serum of patients treated with azidothymidine.
The New England journal of medicine 1986;315(25):1610-1.
1986: Chaisson R E; Ross J; Gerberding J L; Sande M A
Clinical aspects of adult epiglottitis.
The Western journal of medicine 1986;144(6):700-3.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Richard Chaisson

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Living Beings

Geographic Areas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Richard Chaisson (preview)

All Publications